Henry Meds vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Henry Meds beats MEDVi overall, scoring 8.4/10 vs 7.7/10. Henry Meds is more affordable at $199/mo vs $299/mo. Choose Henry Meds for users seeking a well-rounded program with good pricing and m. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Henry Meds and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Henry Meds
#6 of 40Popular telehealth platform offering a wide range of GLP-1 options with competitive pricing and reliable service.
Visit Henry MedsMEDVi
#21 of 40Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
Visit MEDVi| Feature | Henry Meds | MEDVi |
|---|---|---|
| Our Score | 8.4/10 | 7.7/10 |
| Starting Price | $199/mo | $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users seeking a well-rounded program with good pricing and medication variety | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #6 | #21 |
Pros & Cons Compared
Henry Meds
Pros
- +Strong medication variety — both brand-name (Wegovy, Zepbound) and compounded options under one roof
- +$199/mo is well-priced for a platform offering both medication types with clinical support
- +Active patient community and responsive support team with typical <4 hour email response times
- +Easy medication switches — can move from compounded to brand-name (or vice versa) without re-enrollment
Cons
- −No insurance billing — $199/mo is entirely out-of-pocket, though they provide superbills
- −Consultation wait times can stretch to 3-5 days during peak periods (January, post-holiday)
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
Henry Meds edges out MEDVi with a score of 8.4/10 vs 7.7/10. If budget is your priority, Henry Meds starts at $199/mo compared to MEDVi's $299/mo. Henry Meds offers both brand-name and compounded medications, giving you more flexibility. Choose Henry Meds if you want: users seeking a well-rounded program with good pricing and medication variety. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.